title: The effect of sodium valproate on plasma ACTH and cortisol concentrations in Cushing's disease and Nelson's syndrome.
authors.forename: A
authors.initials: A
authors.lastname: Kasperlik-Załuska
authors.forename: J
authors.initials: J
authors.lastname: Drac-Kaniewska
authors.forename: B
authors.initials: B
authors.lastname: Migdalska
authors.forename: W
authors.initials: W
authors.lastname: Jeske
authors.forename: T
authors.initials: T
authors.lastname: Wiśniewska-Woźniak
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000037:antagonists & inhibitors / Q000097:blood*; D000328:Adult; D003480:Cushing Syndrome / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006727:Hormone Antagonists; D006801:Humans; D006854:Hydrocortisone / Q000037:antagonists & inhibitors / Q000097:blood*; D008875:Middle Aged; D009347:Nelson Syndrome / Q000097:blood / Q000188:drug therapy*; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D012074:Remission Induction; D014635:Valproic Acid / Q000627:therapeutic use*
chemical_list: D006727:Hormone Antagonists; D014635:Valproic Acid; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone